Luciano Prossomariti
Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Journal: British journal of haematology
Published: April 19, 2016
Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.
Journal: European journal of haematology
Published: April 07, 2013
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major.
Journal: Blood cells, molecules & diseases
Published: February 16, 2013
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters.
Journal: Annals of hematology
Published: December 19, 2012
Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia.
Journal: Blood transfusion = Trasfusione del sangue
Published: December 06, 2012
Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death.
Journal: Blood cells, molecules & diseases
Published: October 17, 2012
Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study.
Journal: Blood cells, molecules & diseases
Published: May 02, 2012
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.
Journal: American journal of hematology
Published: March 20, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026